<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<pubmed-document>
<record>
<header>
<identifier>2747321</identifier>
<setSpec>0025-7753</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:author>del Potro, E</dc:author>
<dc:author>Martínez, R</dc:author>
<dc:author>Villegas, A</dc:author>
<dc:author>Guerra, J L</dc:author>
<dc:author>Llorente, L</dc:author>
<dc:author>Díaz Morfa, M</dc:author>
<dc:author>Alvarez, A</dc:author>
<dc:author>Díaz Mediavilla, J</dc:author>
<dc:author>Krsnik, I</dc:author>
<dc:author>López, J C</dc:author>
<dc:description xml:lang="en">We report our eight year experience remission induction therapy in adult patients with acute myeloblastic leukemia. Overall 67 patients were treated, with a mean age of 43.3 years (range 15-75). Two treatment protocols were used. Complete remission (CR) was achieved in 23 patients of 39 receiving protocol A (58%). The 28 last patients were treated with the more aggressive protocol B, and CR was achieved in 23 patients (82%). CR was achieved in 68% of the overall group. The most outstanding predictive factors were age above 30 years, and M-5 morphology as indicating a poor prognosis.</dc:description>
<dc:type>Comparative Study</dc:type>
<dc:language>es</dc:language>
<dc:date>1989 Apr 29 </dc:date>
<dc:title xml:lang="es">Tratamiento de inducción la remisión en adultos con leucemia aguda mieloide. Ocho años de experiencia con dos protocolos sucesivos.</dc:title>
<dc:title xml:lang="en">[Remission induction treatment in adults with acute myeloid leukemia. 8-year experience with 2 successive protocols].</dc:title>
<dc:publisher>Medicina clinica</dc:publisher>
</metadata>
</record>
</pubmed-document>
